Biopharmaceutical Stocks List

Related ETFs - A few ETFs which own one or more of the above listed Biopharmaceutical stocks.

Biopharmaceutical Stocks Recent News

Date Stock Title
Nov 22 SRPT High Growth Tech Stocks to Watch in November 2024
Nov 22 NVO “No magic wand” for Novo Nordisk, as CagriSema pen supply rumours swirl
Nov 22 NVO Novo Nordisk Plunges 25% in 3 Months: How to Play the Stock
Nov 22 NVO Barclays says buy Novo Nordisk stock 'into this critically important catalyst'
Nov 22 NVO RFK Jr. Spooks Weight-Loss Stocks. Should Eli Lilly, Novo Nordisk Be Worried?
Nov 22 NVO Novo Nordisk said to have contracted Ypsomed to make next gen obesity drug’s pens
Nov 22 NVO Oura rings to track blood sugar, Vaccines vs RFK Jr., and Ozempic 2.0: Pharma news roundup
Nov 21 BMRN Why Is BioMarin Pharmaceutical Inc. (BMRN) Among the Worst Performing Biotech Stocks in 2024?
Nov 21 NVO The FDA Can’t Decide Whether Zepbound Is in Shortage. It’s Good News for Hims & Hers Stock.
Nov 21 BMRN BioMarin: Challenges Mount, But Sale Rumors Make For A Risky 'Buy' Call
Nov 21 NVO Eli Lilly Stock Tumbles As Kennedy Targets Weight Loss Drugs
Nov 21 BMRN Here's Why BioMarin Pharmaceutical (BMRN) is a Strong Value Stock
Nov 21 NVO Pfizer Secures Approval for Hemophilia Drug Hympavzi in the EU
Nov 21 TRVI Trevi Therapeutics to Participate in Piper Sandler 36th Annual Healthcare Conference
Nov 21 NVO Eli Lilly and 2 More Drug Stocks to Buy After RFK-Inspired Drop
Nov 20 NVO More companies covering weight loss drugs for their employees
Nov 20 NVO Weight loss drug makers want more insurance plans to cover Wegovy and Zepbound
Nov 20 NVO Is Novo Nordisk Stock a Buy Right Now?
Nov 20 TWST Twist Bioscience Full Year 2024 Earnings: EPS Misses Expectations
Nov 20 NVO RFK Jr. Sparks New Worries About Obesity Drugs. Here’s What Investors Should Focus on Instead.
Biopharmaceutical

A biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semisynthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living cells used in cell therapy. Biologics can be composed of sugars, proteins, or nucleic acids or complex combinations of these substances, or may be living cells or tissues. They (or their precursors or components) are isolated from living sources—human, animal, plant, fungal, or microbial.

Browse All Tags